Biotest
Olha Wieder, CPA, is a seasoned finance professional with extensive experience in senior leadership roles, currently serving as Senior Director and Head of Group Finance in the CFO division at Biotest AG since January 2017. Prior to this, Olha worked at Deloitte & Touche from 2009 to 2016, focusing on IFRS advisory services and audit for capital markets. Olha's early career included roles in financial consulting and advisory at prominent firms such as PricewaterhouseCoopers, Ernst & Young, and Commerzbank AG. Olha holds a Diplom-Kauffrau (equivalent to M.Sc.) in Business Administration from Humboldt-Universität zu Berlin and an M.Sc. in International Business from the University of Economics in Ternopil.
This person is not in any teams
This person is not in any offices
Biotest
Biotest AG is a Germany-based provider of plasma proteins and biological drugs. The Company, with a chain that extends from pre-clinical and clinical development to worldwide marketing and distribution, mainly specializes in the areas of clinical immunology, hematology and intensive care medicine. Biotest AG develops, manufactures and markets immunoglobulin, coagulation factors and albumins based on human blood plasma. These are used for diseases of the immune and hematopoietic systems. In addition, the Company develops monoclonal antibodies in the indications of cancer of plasma cells and systemic lupus erythematosus, which are produced by recombinant technologies.